A study in humans demonstrated that the mir-106b was significantly increased in the plasma of acute myocardial infarction patients compared to healthy controls via next-generation sequencing, though subsequent RT-qPCR validation in an independent cohort showed no significant difference [Baulina et al. DOI:10.1016/j.yjmcc.2018.07.129]. In a separate human study of severe trauma, the mir-106b showed direct correlations with arterial blood gas HCO3 and base deficit, clinical parameters of injury severity [Uhlich et al. DOI:10.1016/j.surg.2014.06.017]. A review of human forensic studies indicates the mir-106b is recognized as a venous blood-specific miRNA and as an age-related biomarker, showing down-regulation with aging, and has been found decreased in plasma and serum in lung cancer [Silva et al. DOI:10.1016/J.Fsigen.2014.09.002]. In the context of male infertility, the mir-106b is highly expressed in the seminal plasma of asthenozoospermic and azoospermic patients and functions as a biological regulator, promoting proliferation and DNA synthesis in mouse spermatogonial stem cells by targeting Stat3 and Ccnd1 [Ahmed S. Doghish et al. DOI:10.1007/s00210-024-03594-7].